Drugs that are diverted, in an approximate order of popularity
Opiods (opium analogues) such as hydrocodone and Oxycontin. These use similar results to opium & heroin. Pseudoephedrine-containing drugs sold above a counter come utilized as an ingredient to produce methamphetamine. DXM, the active ingredient of Robitussin, is abused for its results which are then similar to Ketamine and PCP. Depressants such as Valium. Antidepressants, which are typically fundamentally stimulants, and come typically snorted by maltreater. A DEA is doing a few act to try & prevent drug diversion. For instance, sales of Pseudoephedrine come limited around certain places.

A bit of critics sense that a importance of drug diversion is glossed on top in the media & popular discussion. E.g., in the recent experience of Rush Limbaugh being accused of abusing hurt-pain pill, it was felt by a select few that a similarity between a pain killers & diacetylmorphine was non processed clear. A higher dose pills of guide trouble killers come typically stronger so wall street rock diacetylmorphine sold inside virtually all cities, & come favorite or even at least utilized indiscriminately by opiate drug maltreater.

A select few critics contend still that drug diversion has been designedly allowed to happen, primarily by opiod manufacturers world health organization profits remove of the addiction of their client. It besides point to fresh products like "dex-alone" which occurs as pill marketed specifically that it contains pure DXM while forgoing more compounds which would develop an adverse burden at a levels of abuse.

Registration of drug suppliers
Twenty-one U.S.C. § 822 of the Controlled Substances Act provides for registration of manufacturers and distributers of Scheduled substances. A criteria for registering manufacturers of Schedule I personally & 2 doses come particularly nonindulgent & require "limiting the importation and bulk manufacture of such controlled substances to a number of establishments which can produce an adequate and uninterrupted supply of these substances under adequately competitive conditions for legitimate medical, scientific, research, and industrial purposes". A Attorney General must make a caring determination that the registration would exist as "consistent with the public interest".

For manufacturers of more doses, & for drug distributors, a regulations come substantially less nonindulgent: "The Attorney General shall register an applicant . . . unless he determines that the issuance of such registration is inconsistent with the public interest". A criteria for two manufacture & distribution is somewhat biased in favor constituted industries, affirmative "past experience" & the record of compliance by owning drug laws[http://www.usdoj.gov/dea/agency/csa.htm].